Superbugs focus of new coalition of scientists, biotech leaders

Mackenzie Bean

August 22, 2019

A group of scientists, policy experts and biotech leaders launched a coalition Aug. 21 to combat superbugs.

The Working to Fight AMR coalition will work to raise awareness about antimicrobial resistance and advocate for policies that incentivize drugmakers to develop new antibiotics…

More from Becker’s Hospital Review here.

NPR

How the pandemic gave power to superbugs

Antibiotics cannot cure COVID. They don’t help a bit. And yet, new data shows that, during the pandemic, COVID patients…

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

The push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model. Six startups have won Food and Drug…

Fighting AMR with a value and subscription model

The recent reintroduction of the Pasteur Bill seeks to address the global threat that antimicrobial-resistant (AMR) infections pose, one subscription…

Scientists use AI to find new antibiotics, but can they climb out of the ‘valley of death’ to the clinic?

Developing a new antibiotic can take as long as 15 years. But in as few as two, the target bug…

Name
First Last
Email
Zipcode
Organization
Title
Email
This field is for validation purposes and should be left unchanged.

Becker's Hospital Review

Superbugs focus of new coalition of scientists, biotech leaders

Mackenzie Bean

August 22, 2019

More

NPR

How the pandemic gave power to superbugs

Wall Street Journal

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

Pharmaceutical Technology

Fighting AMR with a value and subscription model

Fierce Biotech

Scientists use AI to find new antibiotics, but can they climb out of the ‘valley of death’ to the clinic?

Sign up for the latest on fighting AMR